SCHEMBL5124014

SCHEMBL5124014

Cc1cc(-c2ccc(C#N)cc2)ccc1/C=N/O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 1/20 0.42
SCN10A Q9Y5Y9 1/20 0.40
MAP4K4 O95819 1/20 0.39
KIF11 P52732 3/20 0.39
MAPKAPK2 P49137 1/20 0.38
ALDH1A1 P00352 5/20 0.37
CYP2A6 P11509 1/20 0.37
MAPT P10636 3/20 0.36
LMNA P02545 3/20 0.36
HPGD P15428 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM4E B2RXH2 3/20 0.36
GAA P10253 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
USP2 O75604 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
HRH3 Q9Y5N1 2/20 0.35
HDAC2 Q92769 1/20 0.35
DGAT1 O75907 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5124018 1.00 MMP3 (0.42) MMP3SCN10AMAP4K4KIF11MAPKAPK2
SCHEMBL5125596 0.87 CLK4 (0.43) MAP4K4ALDH1A1LMNAHPGDKDM4E
SCHEMBL5125600 0.87 CLK4 (0.43) MAP4K4ALDH1A1LMNAHPGDKDM4E
SCHEMBL4895760 0.80 MAPT (0.44) ALDH1A1MAPTLMNAHPGDNPSR1
SCHEMBL4895767 0.80 MAPT (0.44) ALDH1A1MAPTLMNAHPGDNPSR1
SCHEMBL5113195 0.77 AR (0.63)
SCHEMBL5113193 0.77 AR (0.63)
SCHEMBL5125590 0.74 KMT2A (0.53) MMP3KIF11ALDH1A1MAPTLMNA
SCHEMBL5125595 0.74 KMT2A (0.53) MMP3KIF11ALDH1A1MAPTLMNA
SCHEMBL10304732 0.74 KIF11 (0.50) MMP3MAP4K4KIF11ALDH1A1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7414142-B2 5-aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2008-08-19 US disclosed
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators WYETH (US) 2007-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066637-A1 5-Aryl-indan-1-one oximes and analogs useful as progesterone receptor modulators CYP19A1, PGR, GNRHR MMP3 3486/4885SCN10A 710/4885MAP4K4 3522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.